Subtype
High-Grade Glioma, NOS
CI-CAN-00009391Explore in graph →
75 active trials2 approved drugs11 evidence items
Loading cancer entity…
Subtype
CI-CAN-00009391Explore in graph →
Clinical trials
173 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (30)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03411408 | Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma.(HBO-RT) | unknown | N/A | 24 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT02239952 | HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) | unknown | N/A | 15 | Amsterdam UMC, location VUmcOTHER | 1 |
| Oct 8, 2020 |
| clinicaltrials |
| NCT02416999 | Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas | unknown | N/A | 30 | Hebei Yanda HospitalOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT02333513 | A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation | unknown | N/A | 100 | Hebei Yanda HospitalOTHER | 1 | Apr 9, 2015 | clinicaltrials |
Data updated 22 days agoSource updated May 30, 2023source: clinicaltrials